Navigation Links
ExonHit Reports Proof-of-Concept in Breast Cancer Diagnostic Using its SpliceArray(TM) Platform
Date:3/16/2009

tal service and that is authorized to receive donations and legacies. IGR is a center wholly patient-oriented with a global expertise and the mission to fight cancer. Located South of Paris on an unique site, IGR employs 2,000 professionals working in care, research and teaching. Some IGR figures: 368 beds and places for day-cases, 159 certified physicians, 751 professional caregivers, 161,000 consultations and 43,000 patients cared per year, 14 basic research units, 300 research scientists, and 260 students, researchers and physicians trained per year. For more information, please visit http://www.igr.fr.

About ExonHit Therapeutics

ExonHit Therapeutics (Alternext: ALEHT) is a fast emerging healthcare player active in both therapeutics and diagnostics. The Company is applying its proprietary technology, based on the analysis of alternative RNA splicing, to develop diagnostic tests and innovative treatments for neurodegenerative diseases, especially Alzheimer's disease and cancers. ExonHit has a balanced investment strategy with internal development programs and strategic collaborations, in particular with bioMerieux and Allergan.

ExonHit is headquartered in Paris, France and has a U.S. facility in Gaithersburg, Maryland. The Company is listed on Alternext of NYSE Euronext Paris. For more information, please visit http://www.exonhit.com.

Disclaimer

This press release contains elements that are not historical facts including, without limitation, certain statements on future expectations and other forward-looking statements. Such statements are based on management's current views and assumptions and involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those anticipated.

In addition, ExonHit The
'/>"/>

SOURCE ExonHit Therapeutics SA
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ExonHit Therapeutics Reports Advancements in the Clinical Development of EHT 0202, its Phase II Drug for Alzheimers Disease
2. ExonHit Therapeutics Expands Strategic Collaboration With Allergan
3. ExonHits EHT 0202 Counters Scopolamines Detrimental Effects on Cognition in Humans
4. Alimera Reports Favorable Safety and Efficacy Results From the 12-Month Interim Readout of the Human PK Iluvien(TM) Study
5. Terumo Heart, Inc. Reports Clinical Progress in the DuraHeart(TM) U.S. Pivotal Trial as NewYork-Presbyterian Hospital/Columbia University Medical Center Implants First Patient
6. Isolagen, Inc. Reports Positive Top-line Results from Phase II/III Study of Isolagen Therapy(TM) to Treat Moderate to Severe Acne Scars: Study Meets All Primary Efficacy Endpoints and is Statistically Significant
7. Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data on KRX-0401 (Perifosine) in Combination with Bortezomib (+/- Dexamethasone) at the 12th International Multiple Myeloma Meeting
8. Novavax Reports Positive Preclinical Results for a Novel, Broadly Cross-Protective H5N1 Pandemic Influenza Virus-like Particle (VLP) Vaccine Candidate
9. Rosetta Genomics Reports First Ever In-Vivo Efficacy Data for a Systemic MicroRNA Therapeutic for Liver Cancer
10. Video: Zometa(R) Reduces Risk of Breast Cancer Recurrence in Premenopausal Women, Study in The New England Journal of Medicine Reports
11. Pieris Reports Development Progress for Anticalin(R) PRS-050, a Next Generation VEGF Antagonist
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... Lupin , Strides ... MPP Sub-licensees to Fourteen Companies     ... expansion of its network of generic manufacturers to 14 companies ... antiretrovirals (ARVs). New companies Lupin and Strides Arcolab recently signed ... the MPP licensed from ViiV Healthcare two months after its ...
(Date:7/1/2015)... July 1, 2015  Celsion Corporation (NASDAQ: CLSN ... Michael H. Tardugno , Chairman, President and CEO, ... Healthcare Conference on Wednesday, July 8, 2015, at 4:15 ... Parker Meridien Hotel located at 119 W. 56th Street, ... A copy of the presentation will be available ...
(Date:7/1/2015)... July 1, 2015 Egalet Corporation (Nasdaq: ... pharmaceutical company focused on developing, manufacturing and marketing ... Radie , president and chief executive officer, is ... He will provide an update on Egalet,s marketed ... Nasal Spray, approved product OXAYDO ™ (oxycodone ...
Breaking Medicine Technology:The Medicines Patent Pool Increases its Generic Manufacturing Network to Ramp-Up Production of Low Cost Antiretrovirals (ARVs) 2The Medicines Patent Pool Increases its Generic Manufacturing Network to Ramp-Up Production of Low Cost Antiretrovirals (ARVs) 3Celsion Corporation to Present at Cantor Fitzgerald's Inaugural Healthcare Conference on July 8, 2015 2Egalet to Present at Upcoming Conferences This Summer 2Egalet to Present at Upcoming Conferences This Summer 3
... First Totally Noninvasive Cardiovascular Monitor... -- AMSTERDAM, November 18, 2010 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... function(data) { var s = ,; var first_result; // Results are keyed by longUrl, so we need to grab ...
... 2010 Royal Philips Electronics (NYSE: PHG, AEX: ... of neonatal medical equipment, announced today that they ... a more complete portfolio of perinatal care solutions. ... home monitoring, neonatal incubators and warmers, jaundice management, ...
Cached Medicine Technology:BMEYE Receives FDA Clearance to Launch ccNexfin, the First Totally Noninvasive Cardiovascular Monitor With BP, CO, and Masimo Rainbow SET(R) Technology in the United States 2BMEYE Receives FDA Clearance to Launch ccNexfin, the First Totally Noninvasive Cardiovascular Monitor With BP, CO, and Masimo Rainbow SET(R) Technology in the United States 3BMEYE Receives FDA Clearance to Launch ccNexfin, the First Totally Noninvasive Cardiovascular Monitor With BP, CO, and Masimo Rainbow SET(R) Technology in the United States 4BMEYE Receives FDA Clearance to Launch ccNexfin, the First Totally Noninvasive Cardiovascular Monitor With BP, CO, and Masimo Rainbow SET(R) Technology in the United States 5BMEYE Receives FDA Clearance to Launch ccNexfin, the First Totally Noninvasive Cardiovascular Monitor With BP, CO, and Masimo Rainbow SET(R) Technology in the United States 6BMEYE Receives FDA Clearance to Launch ccNexfin, the First Totally Noninvasive Cardiovascular Monitor With BP, CO, and Masimo Rainbow SET(R) Technology in the United States 7BMEYE Receives FDA Clearance to Launch ccNexfin, the First Totally Noninvasive Cardiovascular Monitor With BP, CO, and Masimo Rainbow SET(R) Technology in the United States 8Philips and Atom Medical Corporation Announce Strategic Alliance to Provide a Complete Neonatal and Perinatal Offering 2Philips and Atom Medical Corporation Announce Strategic Alliance to Provide a Complete Neonatal and Perinatal Offering 3
(Date:7/1/2015)... ... July 01, 2015 , ... For decades, researchers in the genetics ... constant in the brain, never changing after development in the womb. Now, researchers from ... replaced in brain cells throughout life – a process which helps to switch genes ...
(Date:7/1/2015)... York, NY (PRWEB) , ... July 01, 2015 ... ... largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving the ... services – today announced that they will welcome four new members to their ...
(Date:7/1/2015)... ORANGE, Calif. (PRWEB) , ... July 01, 2015 ... ... advanced orthodontic technology and services, today announced that its fifth annual Smile for ... has raised $80,000 for the non-profit organization. In addition to supporting S4L in ...
(Date:7/1/2015)... , ... July 01, 2015 , ... ... a new extraction plant for Linablue®, Spirulina-derived natural blue food coloring. Construction of ... the DIC Group’s U.S. Spirulina* production base, began in May 2014. After commissioning, ...
(Date:7/1/2015)... ... July 01, 2015 , ... The Collaborative for Children and Families ... Trust. The grant will allow CCF to improve quality of care and save costs ... formed to respond to many changes in New York’s Medicaid system. Experts agree that ...
Breaking Medicine News(10 mins):Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 2Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 3Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 4Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 2Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 3Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 4Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 5Health News:The Forum Fundraiser Raises $80,000 for the Smile for a Lifetime Foundation 2Health News:The Forum Fundraiser Raises $80,000 for the Smile for a Lifetime Foundation 3Health News:DIC Strengthens Its Position as the Global Leader for Natural Blue Food Coloring 2Health News:DIC Strengthens Its Position as the Global Leader for Natural Blue Food Coloring 3Health News:The Collaborative for Children and Families Receives a Grant From The New York Community Trust to Build Capacity for Comprehensive Child Welfare 2Health News:The Collaborative for Children and Families Receives a Grant From The New York Community Trust to Build Capacity for Comprehensive Child Welfare 3
... Medifast, Inc.,(NYSE: MED ) today announced ... Eating and Weight Disorders, shows that individuals taking ... when they combine,their drug therapy with a medical ... study, conducted by researchers at the University of,Missouri-Kansas ...
... tool benefits physicians and their patients, ... high-quality,patient care, Independence Blue Cross (IBC) is ... IBC members with chronic,conditions. This summer, physicians ... with several important enhancements. The Registry is ...
... The Office - Are Raising Funds for the ... Lymphoma Research Foundation, ... opportunity to thank the many "employees" of the 48,branches of Dunder ... support during the DMI,s "Summer Splash - United Way,Fundraiser.", Under ...
... SmoothShapes(R) System in Kansas City Area, MERRIMACK, ... on body shaping, Eleme Medical Inc. announced today ... Kansas City plastic surgeon to offer the,SmoothShapes(R) system ... Leawood, Lee,s Summit and Northland Kansas City. Rajeunir,is ...
... towards collecting -- and analyzing -- data,designed to ... and HAMBURG, Germany, July 31 The,field of ... day.,And a new partnership with Washington,s largest biomedical ... is,contributing to that growth., Georgetown University Medical ...
... the levels of Epstein-Barr virus in children with liver transplants, ... recipients with detectable levels of the virus in their blood ... percent maintaining their response when they stopped taking the drug. ... Transplantation , a journal by John Wiley & Sons. The ...
Cached Medicine News:Health News:Medifast Program Combined with Appetite Suppressants Proven to Yield Double the Weight Loss Compared to Suppressants Alone 2Health News:Independence Blue Cross Enhances SMART(R) Registry 2Health News:Independence Blue Cross Enhances SMART(R) Registry 3Health News:Thank You, Dunder Mifflin Infinity 2Health News:New Anti-Cellulite Treatment Prepares Women for Warmer Weather and Beyond 2Health News:New Anti-Cellulite Treatment Prepares Women for Warmer Weather and Beyond 3Health News:Georgetown University Medical Center Collaborates with Indivumed to Develop Cancer Research Database 2Health News:Georgetown University Medical Center Collaborates with Indivumed to Develop Cancer Research Database 3Health News:Georgetown University Medical Center Collaborates with Indivumed to Develop Cancer Research Database 4Health News:Antiviral therapy helps children at risk for post-transplant lymphoproliferative disease 2
... complete imaging access, with nearly 100 percent ... imaging C-Arms can pan from head to ... patient. Anesthesiologists will appreciate this table for ... construction, and ease of operation. The key ...
...
LiquichekCardiac Markers Plus Control LT is a premium, comprehensive cardiac assessment control with many analytes and long stability....
Liquichek Autoimmune Controls are individual controls for monitoring the performance of autoimmune assays....
Medicine Products: